openPR Logo
Press release

South Korea Fabry Disease Market 2023 Share, Size, Key Players, Revenue Analysis | Prudent Markets

06-20-2023 07:33 PM CET | Health & Medicine

Press release from: Prudent Markets

South Korea Fabry Disease Market

South Korea Fabry Disease Market

The South Korea Fabry Disease Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global South Korea Fabry Disease market. This report explores all the key factors affecting the growth of the global South Korea Fabry Disease market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141721/

Report Overview

The South Korea Fabry diseasemarket size stood at around USD xx million in 2019 and is projected to reach xx million by 2028, exhibiting a CAGR of around xx % during the forecast period.

Fabry disease is caused by a mutation in the galactosidase alpha gene, which leads to absent or deficient function of the lysosomal enzyme -galactosidase A. It is a progressive lysosomal storage disease. As GL-3 is not decomposed and accumulates, various clinical symptoms appear throughout the body, including eyes, heart, kidneys, and skin. As Fabry disease is a progressive disease that worsens with age, experts say early diagnosis and treatment are of the utmost importance. Main symptoms and co-morbidities for Fabry disease include angiokeratoma, cornea verticillate (corneal whirling), hearing loss, tinnitus, proteinuria, cardiac hypertrophy & arrhythmias, sweating dysfunction.

Market Drivers

Increasing government efforts towards the improvement of the healthcare sectorsas well as the introduction of new therapies, and many drugs that are in pipelines will drive the market growth in the near future. Additionally, the increasing awareness about the enzyme replacement therapy among people and rising healthcare expenditure towards research and development of new drugs and the acceptance of technologically superior medical devices is expected to drive the market growth.

It is confirmed that there were about 200 Fabry disease patients in Korea as of 2018 but considering the frequency of occurrence of about 1 in 40,000 to 60,000 people, there are likely to be many undiagnosed patients. These undiagnosed cases will impede the market growth.

To Know More About COVID-19 Impact On South Korea Fabry Disease Market @ https://www.prudentmarkets.com/sample-request/141721/

Market Segmentation

By Treatment:

According to type of treatment provided market is segmented into enzyme replacement and gene therapy, chaperone treatment, organ specific treatment, substrate reduction therapy and others. Enzyme replacement therapy is leading the Fabry disease treatment market.

By Diagnosis:

Based on diagnosis the market is segmented into blood tests, urine test, imaging, and others.

Top Players

The current treatment for Fabry Disease involves the use of enzyme replacement therapies (ERTs), whereby patients are given intravenous ?-GAL A enzyme, leading to a reduction of Gb3 levels in the blood. There are currently three ERTs available in this space, namely Sanofi Genzyme's Fabrazyme (agalsidase beta), Takeda's Replagal (agalsidase alfa) and JCR Pharmaceuticals' biosimilar agalsidase beta. Since 2018, Amicus Therapeutics' Galafold (migalastat hydrochloride), a novel oral pharmacological chaperone therapy, has also been available for the treatment of Fabry Disease.

Highlighted Segments of South Korea Fabry Disease Market:

Industry Overview: The first section of the research study covers an overview of the global South Korea Fabry Disease Market, market status and prospects, and product range. In addition, it provides highlights of the major segments of the global Market, i.e., region, type, and application segments.

Competitive Analysis: This report illuminates important mergers and acquisitions, business expansion, product or service differences, market concentration, the competitive status of the global South Korea Fabry Disease Market, and market size by player.

Company Profiles and Key Data: This section covers companies profiling the major players in the global South Korea Fabry Disease Market based on the aforementioned revenue, products, business, and other factors.

Market size by type and application: In addition to providing an in-depth analysis of the industry size by type and application, this section provides research on top end users or consumers and potential applications.

Market Dynamics: This report covers the drivers, trends, and opportunities of the global South Korea Fabry Disease Market. This section also includes Porter's analysis of five forces.

Findings and Conclusions: It provides strong recommendations for new as well as established players for securing a position of strength in the global South Korea Fabry Disease Market.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141721/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global South Korea Fabry Disease Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global South Korea Fabry Disease Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the South Korea Fabry Disease market
Chapter 2: Exclusive Summary - the basic information of the South Korea Fabry Disease Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the South Korea Fabry Disease
Chapter 4: Presenting the South Korea Fabry Disease Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the South Korea Fabry Disease market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Why should you purchase this report?

-Prudent Markets provides the vital historical and analysis data of global South Korea Fabry Disease market.
-The report provides the entire assessment of the future market and altering market scenario or behavior.
-All the business decision could be backed through the several strategic business methodologies offered in the report.
-An extra edge in the competitive market could be obtained from this elaborative research report
-The report offers all the competitive landscape, growth drivers, applications, market dynamics, and other necessary details as well.

Purchase this report (Single User License) @ https://www.prudentmarkets.com/checkout/?id=141721&license_type=su

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the South Korea Fabry Disease Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release South Korea Fabry Disease Market 2023 Share, Size, Key Players, Revenue Analysis | Prudent Markets here

News-ID: 3095706 • Views:

More Releases from Prudent Markets

Booming Residential Toilet Tank Fill Valve Market Forecasted to Expand Rapidly (2025-2033)
Booming Residential Toilet Tank Fill Valve Market Forecasted to Expand Rapidly ( …
A new report from Prudent Markets, titled "Residential Toilet Tank Fill Valve Market 2025-2033," offers an in-depth examination of the industry, including valuable insights into the Residential Toilet Tank Fill Valve market's performance. The report covers competitor dynamics, regional trends, and the latest technological developments shaping the market. This comprehensive analysis is complemented by a detailed table of contents, along with figures, tables, and charts, providing a thorough understanding of the
Commercial Toilet Tank Fill Valve Market to Witness Substantial Growth in the Next Decade (2025-2033)
Commercial Toilet Tank Fill Valve Market to Witness Substantial Growth in the Ne …
A new report from Prudent Markets, titled "Commercial Toilet Tank Fill Valve Market 2025-2033," offers an in-depth examination of the industry, including valuable insights into the Commercial Toilet Tank Fill Valve market's performance. The report covers competitor dynamics, regional trends, and the latest technological developments shaping the market. This comprehensive analysis is complemented by a detailed table of contents, along with figures, tables, and charts, providing a thorough understanding of the
Commercial Toilet Tank Flush Valve Market Projected to Thrive in the Coming Decade (2025-2033)
Commercial Toilet Tank Flush Valve Market Projected to Thrive in the Coming Deca …
A new report from Prudent Markets, titled "Commercial Toilet Tank Flush Valve Market 2025-2033," offers an in-depth examination of the industry, including valuable insights into the Commercial Toilet Tank Flush Valve market's performance. The report covers competitor dynamics, regional trends, and the latest technological developments shaping the market. This comprehensive analysis is complemented by a detailed table of contents, along with figures, tables, and charts, providing a thorough understanding of the
Residential Toilet Tank Flush Valve Market Forecast: Strong Expansion Expected from 2025 to 2033
Residential Toilet Tank Flush Valve Market Forecast: Strong Expansion Expected f …
A new report from Prudent Markets, titled "Residential Toilet Tank Flush Valve Market 2025-2033," offers an in-depth examination of the industry, including valuable insights into the Residential Toilet Tank Flush Valve market's performance. The report covers competitor dynamics, regional trends, and the latest technological developments shaping the market. This comprehensive analysis is complemented by a detailed table of contents, along with figures, tables, and charts, providing a thorough understanding of the

All 5 Releases


More Releases for Fabry

U.S. Fabry Disease Market Size Report 2034
On April 28, 2025, Exactitude Consultancy., Ltd. released a research report titled "U.S. Fabry Disease Market". This report covers the global U.S. Fabry Disease market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends.
Top Factor Driving Fabry Disease Treatment Market Growth in 2025: Impact of Incr …
How Are the key drivers contributing to the expansion of the fabry disease treatment market? The rising prevalence of renal diseases is expected to drive the growth of the Fabry disease treatment market. Renal diseases are becoming more prevalent due to genetic factors, lifestyle choices, and environmental influences. Fabry disease, which causes kidney dysfunction, is increasing and requires timely intervention. According to the Australian Bureau of Statistics, kidney disease affected 246,200
Fabry Disease Market Trends Analysis 2030
Fabry disease is a rare X-linked lysosomal storage disorder. This patient has a deficiency in the enzyme alpha galactosidase, which progresses to organ failure. The development of fabry illnesses is mostly caused by abnormal accumulation of a certain fatty substance known as globotriaosylceramide. This aberrant buildup can be detected in the skin, eyes, heart, kidney, brain, gastrointestinal system, and central nervous system, among other body parts. Galactosidase Alpha (GLA) is a
Fabry Disease Market Pipeline 2019 Analysis and Developmental Stages
"Fabry Disease - Pipeline Insight, 2019” report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Fabry Disease development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental Stages: - Clinical - Non-clinical - Inactive: Discontinued
Fabry Disease - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Fabry Disease - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fabry Disease - Pipeline Review, H1 2017, provides an overview of the Fabry Disease (Genetic Disorders) pipeline landscape. Fabry disease is an inherited disorder. Fabry disease results from abnormal deposits of a particular fatty substance (called
Fabry Disease Market Intelligence Report Offers Growth Prospects
Fabry diseaseis also known as Anderson-Fabry disease and alpha-galactosidase A deficiency. It is a rare genetic disorder of lipid metabolism resulting from the deficient activity of the alpha-galactosidase A (a-Gal A) enzyme. The deficiency of the enzyme is caused by the alterations in the genes that instructs the cells to make alpha-galactosidase A (a-Gal A) enzyme. Fabry disease is known to cause variety of systemic symptoms and complications, one of